TrialClinical pharmacology in drug development2016

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin 5 monoclonal antibody, in healthy Japanese male subjects.

Naohiro Tsukamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.